Expert Insights

At the 2023 ACRO Radiation Oncology Summit, Maria Werner-Wasik, MD, discussed preoperative treatment options for stage III non-small cell lung cancer.

At the 2023 ACRO Radiation Oncology Summit, Maria Werner-Wasik, MD, discussed preoperative treatment options for stage III non-small cell lung cancer.

Hyman Muss, MD, outlines the important considerations for providers caring for older patients with breast cancer.

Hyman Muss, MD, details his best practices for delivering effective end-of-life care for patients with breast cancer.

Benjamin Miron, MD, discusses the course of treatment he would take for a patient with advanced urothelial carcinoma with spinal and liver metastasis.

Kelly Hunt, MD, discusses the practice of axillary reverse mapping in the prevention of lymphedema for patients with breast cancer.

At 2023 ESMO Targeted Anticancer Therapies Congress, Alison Schram, MD, discusses the class II/III alterations of BRAF inhibitors.

Dr Hyman Muss offers his insights on how metronomic chemotherapy can fit into the treatment paradigm for patients with breast cancer.

Arielle Medford, MD, outlines the steps she would take to treat a patient with ER-negative, PR-negative, HER2-positive breast cancer.

Koen W. van Besien, MD, recaps a debate in which he argued that patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) and TP53 mutations should undergo allogeneic stem cell transplantation.